bioAffinity Technologies (BIAF) Short term Debt (2021 - 2023)

bioAffinity Technologies has disclosed Short term Debt across 3 years of filings, most recently posting $42334.0 for Q2 2023.

• In Q2 2023, Short term Debt changed N/A year-over-year to $42334.0; the TTM figure through Jun 2023 stood at $42334.0 (changed N/A YoY), while the FY2022 annual figure was $251746.0, up 383.44% from the prior year.
• Short term Debt eased to $42334.0 in Q2 2023, from $168430.0 in the prior quarter.
• Over the last five years, Short term Debt for BIAF reached as high as $500000.0 in Q3 2022 and fell as low as $42334.0 in Q2 2023.
• The 3-year median for Short term Debt is $168430.0 (2023), against an average of $202916.8.
• The widest YoY moves for Short term Debt: up 383.44% in 2022, down 383.44% in 2022.
• A 3-year view of Short term Debt shows it stood at $52074.0 in 2021, then surged by 383.44% to $251746.0 in 2022, then tumbled by 83.18% to $42334.0 in 2023.
• According to Business Quant data, Short term Debt over the past three periods registered $42334.0, $168430.0, and $251746.0 for Q2 2023, Q1 2023, and Q4 2022 respectively.